Find Academic Supervisors

Carlos E. Crespo-HernándezView profile

Professor

• Photochemistry
• Photobiology
• Ultrafast Spectroscopy
• +7 more

Carlos E. Crespo-Hernández is a Professor of Chemistry and Associate Dean for Research at Case Western Reserve University's College of Arts and Sciences. His academic career spans over 15 years at CWRU, with previous appointments as Associate Professor (2014-2019) and Assistant Professor (2007-2014). He also served as Co-Director of the Center for Chemical Dynamics (2008-2018) and currently holds editorial responsibilities as Associate Editor for Photochemistry and Photobiology. PhD from University of Puerto Rico (2002) NIH Postdoctoral Fellow at Ohio State University (2002-2005) Research Associate at Ohio State University (2005-2006) Visiting Professor at University of Puerto Rico, Humacao Campus (2006-2007) His research focuses on light-induced molecular phenomena, particularly in photodynamic therapy and nucleic acid photophysics. Key areas include: Ultrafast spectroscopy of photosensitizers Design of heavy-atom-free phototherapeutic agents Single-cell super-resolution spectroscopy Computational modeling of excited states Development of photonic materials Chemical dynamics and reaction pathways Scientific contributions include: ACS Applied Bio Materials (2025) Annu. Rev. Phys. Chem. (2025) J. Phys. Chem. Lett. (2025) Chem. Eur. J. (2024) Photochem. Photobiol. (2024) Chem. Sci. (2023) His group trains students in advanced analytical techniques including: High-performance liquid chromatography Nuclear magnetic resonance Mass spectrometry Time-resolved spectroscopy Computational methods

Eric T. KoolView profile

Professor

• Organic Chemistry
• Chemical Biology
• Biophysics
• +4 more

Eric T. Kool is a Professor in the Department of Chemistry at Stanford University , where he holds the George and Hilda Daubert Professorship. He is affiliated with interdisciplinary programs including Bio-X , Biophysics , Stanford Cancer Institute , and the Sarafan ChEM-H initiative. His research spans organic chemistry , chemical biology , and biophysics , focusing on designing molecular tools for nucleic acid analysis and manipulation. Key contributions include nonpolar nucleoside isosteres , rolling circle amplification , and fluorescent DNA/RNA probes . His work has enabled DNA replication studies without hydrogen bonding and RNA structure mapping in cellular environments. Recent publications emphasize RNA 2'-OH functionalization , oxidative DNA repair , and CRISPR-Cas9 regulation . His innovations in acylation chemistry and nucleic acid-based data storage highlight his interdisciplinary approach. Scientific Awards : Dreyfus Foundation Teacher-Scholar Award Alfred P. Sloan Foundation Fellowship ACS Arthur C. Cope Scholar Award ACS Pfizer Award Murray Goodman Prize ACS Breslow Award Fellow of AAAS Member of the American Academy of Arts and Sciences Kool has trained over 120 graduate students and postdoctoral researchers , with more than 35 securing academic positions. His lab’s 45 patents underpin five biotechnology companies, and he has delivered over 250 invited lectures globally. He is also an award-winning educator, twice receiving the Humanities & Sciences Dean's Award for Distinguished Teaching at Stanford for his sophomore organic chemistry courses.

• DNA Methylation
• Epigenetics
• Cancer Therapy
• +3 more

Gregoire Rondelet is a researcher specializing in epigenetic cancer therapy, with a focus on DNA methyltransferases and their inhibition. He has collaborated extensively with J. Wouters and other colleagues on structural studies and drug development projects. Key affiliations include University of Liège (inferred from context) Active in structural biology, enzymology, and medicinal chemistry His research explores the molecular mechanisms of DNA methylation, histone interactions, and the design of non-nucleoside inhibitors for cancer treatment. Publications highlight collaborations with European institutions and contributions to structural biology databases. Scientific contributions include: Best Communication Prize at Séminaire des chercheurs Télévie (2015) Targeting DNA methylation for ATLL therapy (2015) His work spans high-impact areas such as cancer epigenetics, enzyme inhibition, and structure-based drug design, with research outputs cited over 197 times (h-index: 4). Activities include participation in international conferences and advanced training programs like the Vienna Summer School.

Annette NeumanView profile

Associate Professor

• Medicinal Chemistry
• Organic Chemistry
• Chemistry Education
• +3 more

Annette Neuman serves as Associate Professor of Chemistry at Emory University's Oxford College. She holds a B.S. in Chemistry from Davidson College (2004) and a Ph.D. in Chemistry from Emory University (2013), with dissertation research focused on antiviral compound development for hepatitis C and HIV therapies. Dr. Neuman joined Oxford College in 2012 and serves as the campus pre-health advisor. B.S. in Chemistry, Davidson College (2004) Ph.D. in Chemistry, Emory University (2013) Her research spans two primary domains: developing novel synthetic methods for medicinally relevant heterocycles (triazoles and thiadiazoles) using C–H activation techniques, and innovating chemistry education through curriculum design focused on structure-function relationships. She employs backward design principles to create student-centered courses that help learners develop expert thinking patterns in organic chemistry. Her educational scholarship particularly targets non-science majors through integrated lab-lecture projects using natural medicinal sources. Dr. Neuman's scholarly output demonstrates consistent integration of synthetic organic chemistry with pedagogical innovation. Her publications reveal strong emphasis on translating complex medicinal chemistry concepts into accessible educational formats while maintaining rigorous synthetic methodology development. The recurring themes across her work include medicinal applications of heterocyclic compounds, student-centered curriculum design, and bridging pharmaceutical research with undergraduate education. As an educator, she has mentored ten undergraduate researchers through Oxford's Research Scholars and SURE programs, presenting collaborative work at regional ACS meetings. Her teaching portfolio includes Principles of Reactivity (Chemistry 202Q/L) and Advanced Reactivity (Chemistry 203Q/L) courses, along with the Discovery 101Q course 'From Peppermint Oil to Penicillin: Natural Sources of Medicine.' Outside academic duties, Dr. Neuman resides in Atlanta with her husband Rob, children Michael and Virginia, and their dog Biscuit, enjoying running and reading in her spare time.

• Theoretical Chemistry
• Photochemistry
• Photophysics
• +6 more

Robert Góra is an Associate Professor at the Faculty of Chemistry, Wrocław University of Science and Technology, specializing in theoretical chemistry with a focus on molecular aggregates, electro-optical properties, and photochemistry of organic molecules. His research bridges prebiotic chemistry and chemical origins of life through computational studies of excitation energy transfer and nonadiabatic deactivation mechanisms. Ph.D. (2002) and D.Sc. (2014) in theoretical/physical chemistry from Wrocław University of Science and Technology M.Sc. (1998) in computational chemistry His work explores photorelaxation pathways in DNA base pairs, solvent effects on photochemistry, and electron-driven proton transfer processes. Recent publications highlight collaborations with international researchers on prebiotic nucleoside formation and photodamage mechanisms in nucleobases. Key article trends include theoretical insights into UV-induced reactions, solvent effects on excited states, and computational modeling of prebiotic molecular systems. His expertise spans ab initio methods, nonadiabatic dynamics, and quantum simulations of intermolecular interactions. Awards: Recurrent Rector's prizes, Foundation for Polish Science scholarships, team awards, and TEMPUS Mobility Grant Administrative roles: Dean's Plenipotentiary for eLearning (2007–2020), Deputy Head of Department of Physical and Quantum Chemistry (2019–2020) Grant reviews: National Science Center (since 2017), Czech and Croatian agencies He contributes to journals like Nature and Physical Chemistry Chemical Physics , with a focus on prebiotic photostability and quantum dynamics of biological systems.

• Enzymes
• Nucleotides
• Physical Organic Chemistry
• +3 more

Professor David Hodgson serves as a Professor in the Department of Chemistry at Durham University, where his research group applies physical organic chemistry to solve biological and synthetic challenges with emphasis on nucleoside chemistry and bioconjugation techniques. Research Focus: Hodgson's work centers on kinetic analysis and physicochemical properties to develop efficient synthetic methodologies. Key innovations include: Overcoming nucleoside solubility limitations through pH manipulation Designing moisture-stable pyrophosphate salts for nucleotide synthesis Creating anionic phosphorylation agents selective for aqueous bioconjugation Engineering protocols for nucleic acid and polysaccharide modification His publication trajectory (2025-2016) reveals expanding applications from fundamental kinetics to carbon dioxide-protein interactions and biological system engineering, demonstrating consistent methodological innovation in physical organic chemistry. Professor Hodgson actively supervises doctoral researchers Alex Greer, Victoria Liu, Lauren Billett, Matthew Waterson, and Willow Baxter. His laboratory maintains integrated projects in nucleotide analog synthesis, enzyme kinetics, and polysaccharide functionalization, translating mechanistic insights into practical synthetic solutions for chemical biology applications.

Marco RadiView profile

Associate Professor

• Pharmaceutical Chemistry
• Drug Discovery
• Antiviral Agents
• +4 more

Marco Radi is an Associate Professor at the University of Parma's Department of Food and Pharmaceutical Sciences. He earned his PhD in Pharmaceutical Chemistry (2004) from the University of Siena, followed by postdoctoral research at the University of Georgia focusing on nucleoside-derived antitumor agents. Since 2014, he has led a research group specializing in drug discovery for viral infections (Dengue, Zika, SARS-CoV-2), cancer, cystic fibrosis, and inflammatory diseases. His research integrates combinatorial chemistry, microwave-assisted synthesis, and computational methods to develop novel molecular scaffolds. Current projects include COST initiatives on signal transduction (CA18133) and cancer nanomedicine (CA17140), and a Cystic Fibrosis Foundation-funded collaboration with University College London. He mentors students in the Pharmaceutical Chemistry and Technology program and has supervised Erasmus delegations. Radi's work has yielded 75+ publications, 6 patents, and awards including the 2009 Start Cup Toscana. His lab emphasizes sustainable chemistry, with recent articles exploring antiviral kinase inhibitors, immunomodulators, and green synthesis techniques. Key methodologies include: Microwave-assisted multicomponent reactions Structure-based drug design In silico screening for polypharmacology He serves on the Editorial Board of the Journal of Chemistry and founded the PANVIRIDE initiative for broad-spectrum antivirals.

Justin NorthView profile

Assistant Professor

• Bacterial Organic Sulfur Metabolism
• Microbial Metabolism
• Biofuels and Bio-products
• +5 more

Justin North is an Assistant Professor in the Department of Microbiology at The Ohio State University, affiliated with the College of Arts and Sciences. His research focuses on bacterial organic sulfur metabolism, microbial pathways for biofuel production, and metabolic interactions in photosynthetic bacteria and pathogens like E. coli. He holds a B.S. in Biology and Physics from Butler University (2006) and a Ph.D. in Microbiology from Ohio State (2012). His work is supported by awards such as the Ruth L. Kirschstein Postdoctoral Fellowship and the DOE EMSL grant. North leads collaborations in renewable energy projects, including engineering algae for biofuel production through the Presidential Research Excellence Catalyst Award. His lab actively mentors graduate and undergraduate students, with recent highlights including Elizabeth Morgan’s DADD RISE fellowship and Dr. Kamal Deep’s postdoctoral work on ethylene synthesis. Research Interests: Bacterial sulfur, carbon, and nitrogen metabolism; photosynthetic bacteria; metabolic pathway discovery; protein structure-function relationships. Key affiliations include the OSU Biochemistry Program, Center for Applied Plant Sciences, and Sustainability Institute. His team’s recent advancements include novel metabolic engineering approaches and insights into microbial enzyme systems critical for industrial applications and human health.

Meng ZhengView profile

Assistant Professor

• Antibiotic Resistance
• Chemical Biology
• Medicinal Chemistry
• +3 more

Meng Zheng is an Assistant Professor in the Department of Medicinal Chemistry/Chemical Biology at Fordham University. Her research focuses on antibiotic resistance mechanisms, bacterial enzyme modulation, and chemical biology tools for studying microbial pathogens. Her lab is located in JMH 530, and she holds office hours in JMH 532. Her work addresses critical challenges in antimicrobial resistance through enzyme inhibition, efflux pump modulation, and polysaccharide engineering. Recent studies include strategies to counteract bacterial resistance enzymes and develop allosteric inhibitors for bacterial chaperones. Dr. Zheng's research trends emphasize chemical synthesis of nucleoside analogues, bacterial surface polysaccharide modulation, and understanding feedback inhibition mechanisms in bacterial nucleotidyltransferases. Though no formal awards are listed, her publications reflect contributions to drug discovery and microbial biochemistry. She advises no listed students but maintains active research collaborations in medicinal chemistry and antibiotic development. Laboratory activities center on synthesizing bioactive molecules and developing assays to study bacterial enzyme function. Future research directions include exploring novel antibacterial strategies targeting bacterial stress responses.

Peter BealView profile

Professor

• Chemical Biology
• RNA Editing
• RNA Interference
• +3 more

Peter Beal is a Professor in the Chemical Biology Program at the University of California, Davis. His research focuses on using synthetic chemistry to study RNA structure, function, and therapeutic applications. Key areas include RNA editing by ADAR enzymes and RNA interference via siRNA modifications. He leads the Beal Lab and collaborates extensively with structural biologists like Andrew Fisher. Appointed UC Davis faculty in 2006 NIH T32 Training Grant Program Director (2015) Fellow of the American Association for the Advancement of Science (2012) Research interests: - Designing nucleoside analogs to interrogate RNA biology - Developing siRNA-based therapeutics with reduced immunogenicity - Elucidating ADAR2's mechanism and site selectivity through structural studies - Creating tools to modulate RNA editing in living cells His NIH-funded projects investigate RNA editing's role in disease and siRNA optimization for clinical use. Recent work includes fluorescent adenosine analogs for real-time editing monitoring and computational screening of siRNA modifiers. Scientific awards: Camille Dreyfus Teacher Scholar (2000), Robert Parry Teaching Award (2005) Grants: Active NIH grants for RNA editing studies and siRNA development. Collaborates with industry on therapeutic siRNA candidates. Labs/Teams: Beal Lab focuses on chemical biology approaches to RNA biology. Active in the UC Davis Chemical Biology Program.

Stephen A. WoskiView profile

Associate Professor

• Bioorganic Chemistry
• Nucleoside Synthesis
• Peptide Nucleic Acids
• +2 more

Stephen A. Woski is an Associate Professor in the Department of Chemistry and Biochemistry at the University of Alabama. His research focuses on bioorganic chemistry, utilizing synthetic organic chemistry to address biological problems at the molecular level. Education: BS, Emory University (1986) PhD, University of Michigan (1991) NIH Postdoctoral Fellow, California Institute of Technology (1991-1994) Research Interests: Synthesis of non-natural nucleosides and peptide nucleic acids (PNAs) Investigating metal complex interactions with DNA Designing molecular electronic devices through modular assembly Developing DNA-binding molecules for pharmaceutical applications Exploring oxidative DNA damage mechanisms Collaborations: Collaborates with the Metzger group on molecular electronics projects.

Diana BarkoView profile

Professor

• Biochemistry
• Enzymology
• Protein Degradation
• +3 more

Dr. Diana Barko is Chair of the Department of Chemistry and Professor of Chemistry at Baldwin Wallace University, specializing in biochemistry and enzymology. Her research focuses on enzyme function and characterization, particularly in protein degradation and nucleic acid metabolism. Her laboratory investigates citrullination—a post-translational modification catalyzed by peptidyl arginine deiminase (PAD)—and collaborates with Dr. Raymond Shively on G-quadruplex stabilizing molecules for cancer therapy. These projects are funded by the Myeloma Foundation in Solon, Ohio. Students in her lab develop enzymatic assays to study reaction pathways and contribute to national conferences. Barko earned her Ph.D. in Chemistry from Case Western Reserve University, where her dissertation characterized lon protease kinetics. Prior to joining Baldwin Wallace in 2007, she completed a postdoctoral fellowship in pharmacology at Case Western Reserve, researching non-natural nucleoside analogs for cancer treatments. Teaching: Chemistry I and II Organic Chemistry Biochemistry Scientific Awards: No scientific awards mentioned in the provided texts. Advising and Grants: Barko mentors undergraduate researchers, emphasizing training in experimental design and data analysis. Her work is funded by the Myeloma Foundation.

MANUEL MARIA PAZ CASTAÑALView profile

Professor

• Organic Chemistry
• Medicinal Chemistry
• Bioactive Compounds
• +5 more

Manuel Maria Paz Castañal is a Professor at the Universidad de Santiago de Compostela , affiliated with the Departamento de Química Orgánica and the Facultade de Química . He contributes to the Instituto de Materiais (iMATUS) and strategic research groups like COBINMA and ReactyCat , focusing on bioactive compounds and catalysis. His work bridges organic synthesis and biomedical applications. PhD in Organic Chemistry (1994), Universidad de Santiago de Compostela Thesis: Síntesis asimétrica de compuestos de interés biológico His research spans mitomycin chemistry , DNA adducts , and gold nanoparticle conjugates . Key areas include: Sequence-selective DNA crosslinking Reductive activation mechanisms Enantioselective synthesis Nanoparticle surface functionalization Recent publications highlight nanotechnology applications in drug delivery and molecular toxicology of mitomycins. He explores stereochemical control in reactions and the interplay of chemical structure with biological activity.

Katherine Seley-RadtkeView profile

Professor

• Medicinal Chemistry
• Synthetic Organic Chemistry
• Drug Design
• +6 more

Katherine Seley-Radtke is a Professor in the Department of Chemistry & Biochemistry at the University of Maryland, Baltimore County (UMBC) and holds a joint appointment with the University of Maryland, Baltimore (UMB) Biochemistry program. With a Ph.D. from Auburn University (1996) and a B.A. from the University of South Florida (1992), her academic career spans institutions like Georgia Tech (1998-2003) and Auburn University (1997-98). She serves on advisory boards for Wayne State University’s NIH FIRST program and Penn State’s NIH T32 training initiative. Education: B.A., University of South Florida (1992) Ph.D., Auburn University (1996) Her research focuses on Medicinal/Synthetic Bioorganic Chemistry , developing fleximer and flex-base nucleoside/nucleotide analogues to combat viral and cancerous diseases. Key projects include: Antiviral agents targeting coronaviruses (SARS-CoV-2, MERS), filoviruses (Ebola), and flaviviruses (Dengue). Anticancer compounds (thiophene-expanded purines, pyrrolo- and thienopyrimidines) showing sub-nanomolar efficacy against lung, colon, leukemia, and breast cancers. Prodrugs for enhanced oral bioavailability of tricyclic nucleosides active against HCV. Her work integrates SAR algorithms , structure-based drug design , and cross-disciplinary chemical biology to overcome drug resistance via molecular flexibility. Honors and Leadership: Baltimore Sun 2021 Women to Watch ISAR Antonín Holý Memorial Award (2020) UMBC Presidential Research Professor (2015-2018) Editor-in-Chief, Annual Reports in Medicinal Chemistry (2022-present) President, International Society for Antiviral Research (2022-2024) Her lab includes 6 graduate students, 3 postdocs, and 4 undergraduates. She has held leadership roles in NIH review panels, Gordon Research Conferences, and the International Society on Nucleosides, Nucleotides & Nucleic Acids (IS3NA).

Mary T. RodgersView profile

Professor

• Mass Spectrometry
• Physical Chemistry
• Analytical Chemistry
• +5 more

Mary T. Rodgers is a Professor of Analytical and Physical Chemistry at Wayne State University (WSU), Detroit, MI. She holds a visiting scientist position at the FELIX Laboratory, Radboud University, Netherlands. Her research focuses on mass spectrometry and spectroscopy, particularly the application of tandem mass spectrometry and theoretical calculations to study ion-molecule reactions, collision-induced dissociation, and infrared spectroscopy of biological and organic molecules. Rodgers earned a B.S. in Chemistry and Mathematics from Illinois State University (1985) and a Ph.D. in Chemical Physics from Caltech (1992). Her postdoctoral work at Caltech and the University of Utah (1992–1997) involved molecular beam spectroscopy and ion cyclotron resonance mass spectrometry. She joined WSU in 1997, becoming Professor in 2006. She was elected to the Wayne State Academy of Scholars in 2019 and served as its Vice President (2021–22) and President (2022–23). Her research group uses state-of-the-art instrumentation, including a Bruker Solarix 7T FT-ICR MS and amaZon ETD QIT MS, to investigate molecular recognition, solvation effects, and structural stability of nucleic acids, peptides, and metal-ligand complexes. Key interests include the impact of modifications (e.g., halogenation, methylation) on glycosidic bond stability and base-pairing energetics. Rodgers has authored over 165 publications and received numerous awards, including the AAAS and APS Fellowships, ASMS Research Award, and WSU Distinguished Faculty Fellowship. She actively organizes conferences like the Lake Arrowhead Conference on Mass Spectrometry and chairs the Gordon Research Conference on Gaseous Ions. She serves on editorial boards for journals like European Journal of Mass Spectrometry and Physical Chemistry Chemical Physics. Her research is funded by NSF grants (CHE-1409420, OISE-0730072) and collaborations with Dutch institutions. She mentors graduate and undergraduate students in experimental and computational mass spectrometry, advancing interdisciplinary research in chemistry and biology.